Skip to main content
. 2022 Sep 30;12:16406. doi: 10.1038/s41598-022-20118-6

Figure 3.

Figure 3

Incidence rate ratios (95% confidence intervals) for primary and secondary outcomes in 0–28 and 29 or more days after the first and second doses of ChAdOx1 (and BNF162b2 vaccines, and RT-PCR-confirmed SARS-CoV-2 infection, between 7 December 2020 and 31 December 2021.